IL-17RA and IL-17RC receptors are essential for IL-17A-induced ELR + CXC chemokine expression in synoviocytes and are overexpressed in rheumatoid blood 1

Journal of Immunology

Volumn 180, Issue 1, 2008, Pages 655-663

  Zrioual, Saloua ^a   Toh, Myew Ling ^a   Tournadre, Anne ^a   Zhou, Yuan ^a   Cazalis, Marie Angélique ^a   Pachot, Alexandre ^a   Miossec, Vincent ^a   Miossec, Pierre ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; ARGININE; GLUTAMIC ACID; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN RECEPTOR 17RA; INTERLEUKIN RECEPTOR 17RC; LEUCINE; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; IL17A PROTEIN, HUMAN; IL17R PROTEIN, HUMAN; IL17RC PROTEIN, HUMAN; INTERLEUKIN 17; INTERLEUKIN RECEPTOR;

ARTICLE; BLOOD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BLOCKING; RHEUMATOID ARTHRITIS; RNA INTERFERENCE; SYNOVIOCYTE; SYNOVIUM; UPREGULATION; CASE CONTROL STUDY; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; IMMUNOLOGY; MALE; METABOLISM;

ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; CHEMOKINE CCL20; CHEMOKINES, CXC; FEMALE; HUMANS; INTERLEUKIN-17; INTERLEUKIN-6; MALE; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-17; SYNOVIAL MEMBRANE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 40449113569     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.1.655     Document Type: Article

References (47)

1. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6: 1123-1132.
2. Park, H., Z. Li, X. O. Yang, S. H. Chang, R. Nurieva, Y. H. Wang, Y. Wang, L. Hood, Z. Zhu, Q. Tian, and C. Dong. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6: 1133-1141.
3. Bettelli, E., Y. Carrier, W. Gao, T. Korn, T. B. Strom, M. Oukka, H. L. Weiner, and V. K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
4. Veldhoen, M., R. J. Hocking, C. J. Atkins, R. M. Locksley, and B. Stockinger. 2006. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24: 179-189.
5. Nakae, S., A. Nambu, K. Sudo, and Y. Iwakura. 2003. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J. Immunol. 171: 6173-6177.
6. Chabaud, M., J. M. Durand, N. Buchs, F. Fossiez, G. Page, L. Frappart, and P. Miossec. 1999. Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum. 42: 963-970.
7. Kotake, S., N. Udagawa, N. Takahashi, K. Matsuzaki, K. Itoh, S. Ishiyama, S. Saito, K. Inoue, N. Kamatani, M. T. Gillespie, et al. 1999. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J. Clin. Invest. 103: 1345-1342.
8. Chabaud, M., F. Fossiez, J. L. Taupin, and P. Miossec. 1998. Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines. J. Immunol. 161: 409-414.
9. Jovanovic, D. V., J. A. Di Battista, J. Martel-Pelletier, F. C. Jolicoeur, Y. He, M. Zhang, F. Mineau, and J. P. Pelletier. 1998. IL-17 stimulates the production and expression of proinflammatory cytokines: IL-β and TNF-α, by human macrophages. J. Immunol. 160: 3513-3521.
10. Katz, Y., O. Nadiv, and Y. Beer. 2001. Interleukin-17 enhances tumor necrosis factor α-induced synthesis of interleukins 1,6, and 8 in skin and synovial fibroblasts: a possible role as a "fine-tuning cytokine" in inflammation processes. Arthritis Rheum. 44: 2176-2184.
11. Kehlen, A., K. Thiele, D. Riemann, and J. Langner. 2002. Expression, modulation and signalling of IL-17 receptor in fibroblast-like synoviocytes of patients with rheumatoid arthritis. Clin. Exp. Immunol. 127: 539-546.
12. Numasaki, M., M. T. Lotze, and H. Sasaki. 2004. Interleukin-17 augments tumor necrosis factor-α-induced elaboration of proangiogenic factors from fibroblasts. Immunol. Lett. 93: 39-43.
13. Takahashi, H., M. Numasaki, M. T. Lotze, and H. Sasaki. 2005. Interleukin-17 enhances bFGF-, HGF- and VEGF-induced growth of vascular endothelial cells. Immunol. Lett. 98: 189-193.
14. Miossec, P. 2003. Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy. Arthritis Rheum. 48: 594-601.
15. Granet, C., W. Maslinski, and P. Miossec. Increased AP-1 and NF-κB activation and recruitment with the combination of the proinflammatory cytokines IL-1β, tumor necrosis factor α and IL-17 in rheumatoid synoviocytes. 2004. Arthritis Res. Ther. 6: R190-R198.
16. Chabaud, M., and P. Miossec. 2001. The combination of tumor necrosis factor α blockade with interleukin-1 and interleukin-17 blockade is more effective for controlling synovial inflammation and bone resorption in an ex vivo model. Arthritis Rheum. 44: 1293-1303.
17. Granet, C., and P. Miossec. 2004. Combination of the pro-inflammatory cytokines IL-1: TNF-α and IL-17 leads to enhanced expression and additional recruitment of AP-1 family members, Egr-1 and NF-κB in osteoblast-like cells. Cytokine 26: 169-177.
18. Chabaud, M., G. Page, and P. Miossec. 2001. Enhancing effect of IL-1: IL-17, and TNF-κ on macrophage inflammatory protein-3κ production in rheumatoid arthritis: regulation by soluble receptors and Th2 cytokines. J. Immunol. 167: 6015-6020.
19. Chevrel, G., G. Page, C. Granet, N. Streichenberger, A. Varennes, and P. Miossec. 2003. Interleukin-17 increases the effects of IL-1β on muscle cells: arguments for the role of T cells in the pathogenesis of myositis. J. Neuroimmunol. 137: 125-133.
20. Kirkham, B. W., M. N. Lassere, J. P. Edmonds, K. M. Juhasz, P. A. Bird, C. S. Lee, R. Shnier, and I. J. Portek. 2006. Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two-year prospective study (the DAMAGE study cohort). Arthritis Rheum. 54: 1122-1131.
21. Strieter, R. M., P. J. Polverini, S. L. Kunkel, D. A. Arenberg, M. D. Burdick, J. Kasper, J. Dzuiba, J. Van Damme, A. Walz, D. Marriott, et al. 1995. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J. Biol. Chem. 270: 27348-27357.
22. Strieter, R. M., M. D. Burdick, B. N. Gomperts, J. A. Belperio, and M. P. Keane. 2005. CXC chemokines in angiogenesis. Cytokine Growth Factor Rev. 16: 593-609.
23. Clark-Lewis, I., B. Dewald, M. Loetscher, B. Moser, and M. Baggiolini. 1994. Structural requirements for interleukin-8 function identified by design of analogs and CXC chemokine hybrids. J. Biol. Chem. 269: 16075-16081.
24. Page, G., G. Chevrel, and P. Miossec. 2004. Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis: interaction with chemokines and Th1 cytokine-producing cells. Arthritis Rheum. 50: 199-208.
25. Yao, Z., M. K. Spriggs, J. M. Derry, L. Strockbine, L. S. Park, T. VandenBos, J. D. Zappone, S. L. Painter, and R. J. Armitage. 1997. Molecular characterization of the human interleukin (IL)-17 receptor. Cytokine 9: 794-800.
26. Toy, D., D. Kugler, M. Wolfson, T. Vanden Bos, J. Gurgel, J. Derry, J. Tocker, and J. Peschon. 2006. Cutting edge: interleukin 17 signals through a heteromeric receptor complex. J. Immunol. 177: 36-39.
27. Arnett, F. C., S. M. Edworthy, D. A. Bloch, D. J. McShane, J. F. Fries, N. S. Cooper, L. A. Healey, S. R. Kaplan, M. H. Liang, H. S. Luthra, et al. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31: 315-324.
28. Toh, M. L., H. Marotte, J. L. Blond, U. Jhumka, A. Eljaafari, B. Mougin, and P. Miossec. 2006. Overexpression of synoviolin in peripheral blood and synoviocytes from rheumatoid arthritis patients and continued elevation in nonresponders to infliximab treatment. Arthritis Rheum. 54: 2109-2118.
29. Pachot, A., J. L. Blond, B. Mougin, and P. Miossec. 2004. Peptidylpropyl isomerase B (PPIB): a suitable reference gene for mRNA quantification in peripheral whole blood. J. Biotechnol. 114: 121-124.
30. Haudenschild, D. R., S. B. Curtiss, T. A. Moseley, and A. H. Reddi. 2006. Generation of interleukin-17 receptor-like protein (IL-17RL) in prostate by alternative splicing of RNA. Prostate 66: 1268-1274.
31. Lacey, D., A. Sampey, R. Mitchell, R. Bucala, L. Santos, M. Leech, and E. Morand. 2003. Control of fibroblast-like synoviocyte proliferation by macrophage migration inhibitory factor. Arthritis Rheum. 48: 103-109.
32. Kageyama, Y., M. Takahashi, E. Torikai, M. Suzuki, T. Ichikawa, T. Nagafusa, Y. Koide, and A. Nagano. 2007. Treatment with anti-TNF-α antibody infliximab reduces serum IL-15 levels in patients with rheumatoid arthritis. Clin. Rheumatol. 26: 505-509.
33. Marotte, H., B. Pallot-Prades, L. Grange, J. Tebib, P. Gaudin, C. Alexandre, J. L. Blond, M. A. Cazalis, B. Mougin, and P. Miossec. 2006. The shared epitope is a marker of severity associated with selection for, but not with response to, infliximab in a large rheumatoid arthritis population. Ann. Rheum. Dis. 65: 342-347.
34. Moseley, T. A., D. R. Haudenschild, L. Rose, and A. H. Reddi. 2003. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev. 14: 155-174.
35. Hwang, S. Y., J. Y. Kim, K. W. Kim, M. K. Park, Y. Moon, W. U. Kim, and H. Y. Kim. 2004. IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-κB- and PI3-kinase/Akt-dependent pathways. Arthritis Res. Ther. 6: R120-R128.
36. Hwang, S. Y., and H. Y. Kim. 2005. Expression of IL-17 homologs and their receptors in the synovial cells of rheumatoid arthritis patients. Mol. Cell. 19: 180-184.
37. Page, G., A. Sattler, S. Kersten, A. Thiel, A. Radbruch, and P. Miossec. 2004. Plasma cell-like morphology of Th1-cytokine-producing cells associated with the loss of CD3 expression. Am. J. Pathol. 164: 409-417.
38. Langrish, C. L., Y. Chen, W. M. Blumenschein, J. Mattson, B. Basham, J. D. Sedgwick, T. McClanahan, R. A. Kastelein, and D. J. Cua. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201: 233-240.
39. Hymowitz, S. G., E. H. Filvaroff, J. P. Yin, J. Lee, L. Cai, P. Risser, M. Maruoka, W. Mao, J. Foster, R. F. Kelley, et al. 2001. IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. EMBO J. 20: 5332-5341.
40. + T lymphocytes. Cell Res. 16: 902-907.
41. Liang, S. C., X. Y. Tan, D. P. Luxenberg, R. Karim, K. Dunussi-Joannopoulos, M. Collins, and L. A. Fouser. 2006. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203: 2271-2279.
42. + T helper cells. Cell 126: 1121-1133.
43. Cross, A., D. Bakstad, J. C. Allen, L. Thomas, R. J. Moots, and S. W. Edwards. 2005. Neutrophil gene expression in rheumatoid arthritis. Pathophysiology 12: 191-202.
44. Belperio, J. A., M. P. Keane, D. A. Arenberg, C. L. Addison, J. E. Ehlert, M. D. Burdick, and R. M. Strieter. 2000. CXC chemokines in angiogenesis. J. Leukocyte Biol. 68: 1-8.
45. Page, G., and P. Miossec. 2004. Paired synovium and lymph nodes from rheumatoid arthritis patients differ in dendritic cell and chemokine expression. J. Pathol. 204: 28-38.
46. Matsui, T., T. Akahoshi, R. Namai, A. Hashimoto, Y. Kurihara, M. Rana, A. Nishimura, H. Endo, H. Kitasato, S. Kawai, et al. 2001. Selective recruitment of CCR6-expressing cells by increased production of MIP-3α in rheumatoid arthritis. Clin. Exp. Immunol. 125: 155-161.
47. Haringman, J. J., T. J. Smeets, P. Reinders-Blankert, and P. P. Tak. 2006. Chemokine and chemokine receptor expression in paired peripheral blood mononuclear cells and synovial tissue of patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis. Ann. Rheum. Dis. 65: 294-300.